top of page

Kuros' share price rally is not over yet

ARKUDOS
Jun 13, 2024
1 min read

The small medtech company is celebrating great success on the market for bone replacement products and on the stock exchange. Simon Götschmann, fund manager of Arkudos 130/30 Swiss Equity Alpha and Kuros Investor, shares his views on the stock with Finanz+Wirtschaft.

Recent Posts

See All

Swiss equities will outperform US equities

MONEYMAKER

3 reasons in favour of a short-term stock rally

Simon Götschmann, Managing Partner ARKUDOS 1 Historically the central banks' interest rate hikes have had an effect 15-18 months after...

Comments

bottom of page